This study aimed to measure the effectiveness of weekly school-based IFA supplementation on anemia status and Hb, and to determine a minimum effective number of IFA tablets associated with a reduction in anemia prevalence over a 30–36-week school year, with tablets provided weekly, in a prospective cohort of Ghanaian adolescent schoolgirls. This evidence concerns the gene GSTM1 and anemia (phenotype).